Targeted Oncology
Advertisement
Articles by Targeted Oncology
Experts review clinical cases and best practices for managing relapsed/refractory DLBCL.
A key opinion leader provides an overview of emerging data for a promising CD-19 targeted therapy and discusses how it has impacted the treatment paradigm.
Experts in breast oncology review 3 clinical cases of HER2+ breast cancer and discuss individualized treatment approaches for each patient.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Ubamatamab Shows Durable Responses in Low-Grade Serous Ovarian Cancer
2
What Stood Out at IMS 2026? Five Myeloma Experts Weigh In
3
Pirtobrutinib Gains FDA Approval for Frontline CLL/SLL in Select Patients
4
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
5